These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5234177)
41. Studies of a complement-fixing antigen from group A streptococcal L forms. I. Preparation and preliminary tests in rabbits and man. CRAWFORD YE J Immunol; 1960 Jan; 84():86-92. PubMed ID: 13812728 [No Abstract] [Full Text] [Related]
42. A latex agglutination test for measuring antibodies to Streptococcal mucopeptides. Heymer B; Schachenmayr W; Bültmann B; Spanel R; Hafferkamp O; Schmidt WC J Immunol; 1973 Aug; 111(2):478-84. PubMed ID: 4197986 [No Abstract] [Full Text] [Related]
43. Further studies on the soluble epsilon-antigen of the mouse. Klein PA; Lindenmann J Pathol Microbiol (Basel); 1965; 28(4):698-703. PubMed ID: 4953745 [No Abstract] [Full Text] [Related]
44. Production of hemorrhagic necrosis in guinea pigs with anti-streptococcal antisera. Lange CF Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):263-71. PubMed ID: 4354864 [No Abstract] [Full Text] [Related]
45. Immunological evidence of a surface structure common to Streptococcus pyogenes preparation OK-432 and mouse ascites tumor cells. Sasaki M; Kunimatsu M Microbiol Immunol; 1980; 24(3):259-64. PubMed ID: 7412593 [No Abstract] [Full Text] [Related]
46. Experimental and clinical studies on the antitumor activity of a streptococcal preparation (OK-432). Kaibara N Jpn J Exp Med; 1974 Oct; 44(5):399-411. PubMed ID: 4436979 [No Abstract] [Full Text] [Related]
47. Cell-sensitizing products of streptococci. Dishon T; Finkel R; Marcus Z; Ginsburg I Immunology; 1967 Dec; 13(6):555-64. PubMed ID: 4294327 [TBL] [Abstract][Full Text] [Related]
48. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM. Saha S; Mondal S Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041 [TBL] [Abstract][Full Text] [Related]
49. [Reactive changes in leukocytes in bacterial allergy]. Sakharov PP; Gudkova EI; Kudrina GP Klin Med (Mosk); 1971 Mar; 49(3):80-7. PubMed ID: 4935018 [No Abstract] [Full Text] [Related]
50. [Experimental contribution to the analysis of the immunological reactions of ocular structures in presence of heterologous tumors. (a). Mouse ascites tumor graft in the rabbit cornea. (b). Mouse ascites tumor wrapped in autoplastic membrane grafted in the anterior chamber of the guinea pig eye]. Claudio C; Corrado F Riv Anat Patol Oncol; 1969; 35():292-309. PubMed ID: 5404378 [No Abstract] [Full Text] [Related]
51. [Immunobiological properties of cytoplasmic fractions of streptococcus group A. I. Increased immediate sensitivity to streptococcal cytoplasm]. Avdeeva ZhI; Evseev VA Zh Mikrobiol Epidemiol Immunobiol; 1972 Jun; 49(6):70-5. PubMed ID: 5071625 [No Abstract] [Full Text] [Related]
52. Crohn disease arthropathy: antigens in synovial fluid share epitopes with strains of two species of viridans streptococci. Baker SJ; Jacob E; Bowden GH Scand J Gastroenterol; 2000 Mar; 35(3):287-92. PubMed ID: 10766323 [TBL] [Abstract][Full Text] [Related]
53. [Antigenic and pathogenic properties of streptococcal intracellular antigens]. Rassokhina II; Kaplanskiĭ AS; Tustanovskiĭ AA Vopr Revm; 1967; 7(2):11-6. PubMed ID: 5306232 [No Abstract] [Full Text] [Related]
54. [Tolerance induction by passage of the antigen with tumor cells]. Bundschuh G Radiobiol Radiother (Berl); 1983; 24(4):525-30. PubMed ID: 6647799 [No Abstract] [Full Text] [Related]
55. Immunologic enhancement of tumor xenografts by pepsin-degraded immunoglobulin. Broder S; Whitehouse F Science; 1968 Dec; 162(3861):1494-5. PubMed ID: 4177430 [TBL] [Abstract][Full Text] [Related]
56. A rabbit IgG antigenic marker detected by 19S anti-IgG present in streptococcal antisera. Chiao JW; Bokisch VA; Christian CL; Krause RM J Immunol; 1974 Feb; 112(2):627-32. PubMed ID: 4544360 [No Abstract] [Full Text] [Related]
57. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein. Yamamoto Y; Tadatomo Y; Okamura S Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471 [No Abstract] [Full Text] [Related]
58. Experimegts with the "antigen loss factor". Ben-Hur N Plast Reconstr Surg; 1969 Jan; 43(1):61-5. PubMed ID: 4885277 [No Abstract] [Full Text] [Related]
59. Experimental studies on the interaction between anti-type B streptococcal antibody and animal heart tissue. Kyogoku M Acta Pathol Jpn; 1968 Aug; 18(3):287-306. PubMed ID: 4887104 [No Abstract] [Full Text] [Related]
60. Antibody formation for malignant tumor. 3. Antigenicity of peptide of ribosomal digest in Ehrlich ascites tumor. Yamamoto Y; Jituiki D; Yabuki Y Acta Med Okayama (1952); 1970 Oct; 24(5):534-7. PubMed ID: 4256472 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]